Details for Patent: 11,844,804
✉ Email this page to a colleague
Which drugs does patent 11,844,804 protect, and when does it expire?
Patent 11,844,804 protects XYOSTED (AUTOINJECTOR) and is included in one NDA.
This patent has seven patent family members in four countries.
Drugs Protected by US Patent 11,844,804
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-001 | Sep 28, 2018 | RX | Yes | Yes | 11,844,804 | ⤷ Subscribe | METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY | ⤷ Subscribe | ||||
Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-002 | Sep 28, 2018 | RX | Yes | Yes | 11,844,804 | ⤷ Subscribe | METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY | ⤷ Subscribe | ||||
Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-003 | Sep 28, 2018 | RX | Yes | Yes | 11,844,804 | ⤷ Subscribe | METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,844,804
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 2939791 | ⤷ Subscribe | |||
European Patent Office | 3107547 | ⤷ Subscribe | |||
European Patent Office | 4062918 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |